Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIFOSTINE vs AMIKACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIFOSTINE vs AMIKACIN: Safety Overview

Metric AMIFOSTINE AMIKACIN
Total FAERS Reports 125 11,312
Deaths Reported 7 2,114
Death Rate 5.6% 18.7%
Hospitalizations 35 4,686
Average Patient Age 53.3 yrs 54.3 yrs
% Female Patients 45.4% 57.4%
FDA Approval Date Dec 8, 1995 Approved Prior to Jan 1, 1982
Manufacturer N/A Insmed Incorporated
Route N/A RESPIRATORY (INHALATION)
Marketing Status Discontinued Discontinued